Harvard Bioscience
HBIO
#9199
Rank
NZ$0.15 B
Marketcap
$3.46
Share price
0.52%
Change (1 day)
-51.87%
Change (1 year)

Earnings for Harvard Bioscience (HBIO)

Earnings in 2024 (TTM): -NZ$21.72 Million

According to Harvard Bioscience's latest financial reports the company's current earnings are NZ$97.73 Million. In 2023 the company made an earning of -NZ$4.58 Million, an increase over its 2022 earnings that were of -NZ$16.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harvard Bioscience from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$21.72 Million374.46%
2023 -NZ$4.58 Million-72.15%
2022 -NZ$16.44 Million6456.43%
2021 -NZ$0.26 Million-98.08%
2020 -NZ$13.06 Million32.53%
2019 -NZ$9.86 Million-31.01%
2018 -NZ$14.29 Million243.9%
2017 -NZ$4.16 Million-24.66%
2016 -NZ$5.52 Million-14.69%
2015 -NZ$6.47 Million-181.68%
2014 NZ$7.9 M-9.97%
2013 NZ$8.78 M120%
2012 NZ$3.99 M-50.9%
2011 NZ$8.13 M-52.51%
2010 NZ$17.12 M-2.53%
2009 NZ$17.57 M28.26%
2008 NZ$13.69 M-20.05%
2007 NZ$17.13 M13.96%
2006 NZ$15.03 M17.59%
2005 NZ$12.78 M57.37%
2004 NZ$8.12 M-37.31%
2003 NZ$12.95 M208.03%
2002 NZ$4.2 M-168.71%
2001 -NZ$6.13 Million-66.89%
2000 -NZ$18.5 Million